- Report
- October 2024
- 183 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- April 2025
- 194 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- March 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- October 2024
- 128 Pages
Global
From €3636EUR$4,000USD£3,087GBP
- Report
- March 2024
- 90 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- November 2021
- 844 Pages
Global
From €4545EUR$5,000USD£3,859GBP
- Book
- January 2011
- 404 Pages
- Book
- October 2023
Global
- Book
- November 2021
Global
- Book
- September 2021
- 358 Pages

The Neuroprotection market within the context of Neurology Devices is focused on the development of products that protect the brain from damage caused by stroke, traumatic brain injury, and other neurological disorders. These products are designed to reduce the risk of long-term neurological damage and improve patient outcomes. Neuroprotection products include drugs, medical devices, and other therapies that can be used to reduce the risk of neurological damage. These products are used to reduce the risk of stroke, traumatic brain injury, and other neurological disorders.
The Neuroprotection market is a rapidly growing segment of the Neurology Devices market, with a focus on improving patient outcomes and reducing the risk of long-term neurological damage. Companies in this market include Medtronic, Abbott, Boston Scientific, Stryker, and Johnson & Johnson. Show Less Read more